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ABSTRACT 
Being a modern technique with the ability of studying, discovering, probing and analyzing 
the expression of thousands genes, even the whole genome in the only one experiment, 
microarray proved to be a powerful tool for cancer research especially at molecular level. 
Employing the potential anticancer compound 1-(5,7-dimetoxy-2,2-dimetyl-2H-cromen-8-yl)-
but-2-en-1-on (2B2D in short) and LU-1, the human lung cancer cells as research objects, we 
successfully hybridized the cy3/5 incorporated cDNA with Phalanx HOV5 microarray. The 
results showed 742 genes that got effected with equal or over two folds change under 2B2D 
treatment. Among - those, 386 genes were up-regulated while the other 356 were down-
regulated. The Nuclear factor (erythroid-derived 2, regulatory factor X domain containing 1, 
fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) and E2F 
transcription factor 8 genes were the most stimulated by our compound. The genes that named 
as Solute carrier family 7 (cationic amino acid transporter, system) member 11, kelch-like 24 
and Hypothetical LOC344887 were the most down in action. 
Keywords: cDNA, cyanine, LU-1, Mallotus apelta, microarray, spectrophotometer 
1. INTRODUCTION 
The compound 1-(5,7-dimetoxy-2,2-dimetyl-2H-cromen-8-yl)-but-2-en-1-on (2B2D in 
short) found in the Vietnamese plant Mallotus apelta was patent registered by The Institute of 
Natural Product Chemistry, Vietnam  Academy of Science and Technology for its novel 
chemical structure and the anticancer effect as well. The compound was proved to possess the 
effective anticancer ability in vitro. The pharmaceutical activity of this promising compound is 
in the process of in vivo testing [1]. However, the molecular acting mechanism of this compound 
had not been studied. In order to study the working mechanism of a promising agent, microarray 
technique has been recently proved to be effective and feasible. 
Based on Southern Blotting technique, microarray is learned as a new tool for gene 
expression analysis. Microarray is the amazing thing in science following the availability of 
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human genome sequence information which allow us to do experiments on a genome-wide 
scale. DNA microarrays offer the ability to look at the expression of thousands of genes or even 
the whole enome of a living species in a single experiment [2, 3, 4]. This technology provides a 
versatile plattform for utilizing information from the Human Genome Project to benefit human 
health, especially in cancer research [5]. 
A microarray is an orderly arrangement of known or unknown DNA samples attached to a 
solid support. Each DNA spot on the microarray (called the probe) is usually less than 200 
micrometer in diameter and an entire array typically contains thousands of spots. Many different 
design formats are possible. The probes attached to the solid support can be small 
oligonucleotides, cDNAs or genomic sequences [6]. The array may be formatted by 
photolithographic synthesis of oligonucleotides in situ, or the DNA samples may be applied 
directly to the array surface by pins, nibs or inkjet technology [7]. 
Basically, measuring the mRNA level will create the profile of gene expression of under 
study sample at the testing time. Expression profiling is very important because it is the set of 
expressed genes and interplay between the products encoded by them that determines the 
phenotype of a cell [8]. The microarray experiment involves in preparations the fluorescently 
labeled cDNA from mRNA, isolated from two different conditions, to be compared from two 
contrasted colors such as cy3 (green) and cy5 (red). The resulting mixture of labeled cDNAs is 
hybridized to a large number of genes placed individually spotted on a microarray glass slide. 
Hybridization results are then be analyzed by determining the relative fluorescent intensity at 
each gene spot with the use of a laser scanner. Spots that fluoresce dominantly with one label or 
the other indicate a gene that differentially up-regulated or down-regulated in the sample under 
the condition of the study [9].  
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Figure 1. (A) Chemical structure of the compound 2B2D; (B) The image of the box 
containing a whole human genome microarray (from Phalanx) 
Learning all advantages of microarray, we decided to apply this technique for studying the 
anticancer mechanism of the compound 2B2D at molecular level. The results of our research are 
announced in the below report.  
2. MATERIALS AND RESEARCH METHODS 
2.1. Materials 
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The compound 2B2D was kindly provided by Assoc. Prof. Phan Van Kiem, Institute of 
Natural Product Chemistry (INPC), Vietnam Academy of Science and Technology (VAST). The 
whole human genome microarrays were purchased from Phalanx Biotech Group. The other 
chemicals such as RNase-free water (DEPC treated), oligo dT primer (16- to 18-mer) at 1 µg/µl, 
3 M Sodium Acetate, pH 5.2, 100% Ethanol, 70 % Ethanol, Superscript II Reverse 
Transcriptase, 5X first strand buffer RNase A (4 mg/ml), RNase H (2 unit/µl), PCR CleanUp 
Kit, RNeasy® RNA Isolation kit etc. were purchase from Qiagen, Invitrogen etc. 
The cell line LU-1 (human lung carcinoma) was kindly provided by Prof. Dr. J M Pezzuto, 
University of Hawaii at Hilo, US. 
2.2. Methods 
LU-1 cells treatment with 2B2D for total RNA extraction: The cells LU-1 were cultured in the 
DMEM (GIBCO) supplemented with 10 % FBS, 1 % PSF, 10 % Sodium pyruvat (GIBCO). The 
cells were subcultured after 3 - 5 days at the rate (1 : 3) and kept in the incubator at 37 oC, 5 % 
CO2. LU-1 were seeded at the concentration 1 × 106 cells/dish and treated with 2B2D at 0,5 
µg/ml and 1 µg/ml. DMSO 0.1 %  was used as control.  
Total RNA isolation and purification: After 24 hours treated with 2B2D, the cells LU-1 were 
collected for total RNA isolation with the use of RNeasy® RNA Isolation kit (Qiagen). The 
purified RNA were quantitied by using Nanodrop ND-1000 version 3.3.0 Spectrophotometer 
(Thermo Scientific) and qualified by electrophoresis on agarose gel. 
cDNA synthesis from total RNA: Since this process involves in fluorescence, all research steps 
require the dark condition strictly. Toward 10 - 20 µg total RNA or 0.1 - 0.5 µg of tRNA, the 
contents of one reaction will be: 8 µL 5X First Strand reaction buffer (Superscript II, 
Invitrogen); 1,5 µL AncT primer (5’-T20VN, 100 pmol/µL); 3 µL dNTP-dCTP (6.67 mM dATP, 
dGTP, dTTP, GE Healthcare); 1 µL 2 mM dCTP (GE Healthcare); 1 µL 1 mM Cyanine 3-dUTP 
or Cyanine 5-dUTP (GE Healthcare); 4 µL 0.1 M DTT (Invitrogen); 20 µg total RNA; Nuclease-
free water up to 40 µL. Incubation of the reaction at 65 oC in 5 minutes in the dark to degrade the 
total RNA. Cooling the samples at 42 oC in 5 minutes before adding enzyme. Providing 2 µL 
reverse transcriptase (SuperScript II, Invitrogen) and continuing the reaction at  42 oC in 2 hours. 
Stop the reaction by adding 4 µL 50 mM EDTA (pH 8.0) and 2 µL 10 N NaOH; Neutralization 
by adding 4 µL 5 M acetic acid. Clean up the CyDye-cDNA with Qiagen PCR CleanUp Kit. 
Microarray Hybridization: The whole process with pre-hybridization, hybridization and 
washing steps were completed by following microarray producer’s instructions with some minor 
modification to fit our laboratory conditions. 
Scanning, Imaging and Data analysis: The GeneTAC UC-4 system of GENOMIC 
SOLUTIONS was used to scan the array after hybridization. The image were captured by this 
system by followings the instruction of the machine producer. And the raw data as well as the 
images were sent to PHALANX BIOTECH. GROUP, Taiwan for data analysis. 
3. RESULTS AND DISCUSSION 
There are three major steps involving to a typical microarray experiment: preparation of the 
array; preparation of Cdna probes and hybridization; and final scanning, imaging and data 
analysis. We hereby reported our experiment results with the Human OneArray® Whole 
Genome DNA V5 microarray. 
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3.1. Array preparation 
Human OneArray® Whole Genome DNA V5 microarrays are made of sense-strand 
polynucleotide probes spotted onto a proprietary chemical layer coated on top of a 1” × 3” (25 
mm × 75 mm) standard-format microarray glass slide. Updated information of genome content 
from public domains is used to design approximately 30,000 highly sensitive long-
oligonucleotide probes for monitoring the expression level of corresponding protein-coding 
genes. Each probe is spotted onto the array in a highly consistent manner using a proprietary, 
non-contact spotting technology adapted for microarray manufacturing. Each microarray 
contains 30,275 oligonucleotides: 29,187 human genome probes, and 1,088 experimental control 
probes. Each oligonucleotide probe is designed to hybridize to a specific target gene described in 
the current public domain contents, such as NCBI Reference Sequence (RefSeq) Database and 
Ensembl Database.  
According to the producer’s instruction, the array requires a pre-hybridization step prior to 
hybridization of the labeled target. The pre-hybridization step reduces background signals and 
increases the performance of the microarray. The pre-hybridization step was completed by 
carefully following the instructions of the producer. After pre-preparation, the array could be 
kept in the dark box for as long as one week before cDNA hybridization. 
3.2. Results of cDNA probing and Hybridization 
As reported in another paper, the optimized conditions for 2B2D treatment on LU-1 cells 
were at 0,5 µg/ml and 1 µg/ml in the period of 24 hours and 48 hours of experiment in order to 
receive the maximum amount of tRNA. However, 0.5 µg/ml of 2B2D treated at 24 hour 
condition were decided for further microarray study.  
Good dye incorporation rates are important for yielding the best data from microarray 
hybridization. Incorporation rates of 30-60 dye molecules per 1000 bases (17 - 33 bases /dye 
molecule) yield the most usable data. Rates below 20 dyes per 1000 bases (50 bases / dye) are 
very low and may lead to loss of signal of many targets. It is not recommended to perform 
hybridization with samples of low dye incorporation efficiency.  
After fluorescent probing, the cDNA samples were quality checked by electrophoresis on           
1 % (w/v) TAE agarose gel. The figure 3 proved that fluorescent dye cyanine was firmly 
incorporated into cDNA molecules. The cDNA samples therefore were ready for hybridizing 
with the microarray. We also calculated the pmol of cDNA samples that probed with cyanine by 
using the OD values from UV-visible spectrophotometer. All tested samples had over 142 pmol 
of cDNA labeled with probes (data not showed). Thus, the cDNAs were qualified for 
hybridization with the Human OneArray® Whole Genome DNA V5 microarray. 
                       (A)                                                 (B)                
                                              
Figure 2. (A) The 2B2B 
treated sample probing with 
Cy5; (B) The control  sample 
probing with Cy3 
 
  
Study the anticancer mechanism of the promissing compound 2B2D by using microarray technique 
 
271
After following the instruction of Phalanx Biotech to hybrid our cDNA samples with the 
pretreated array, the slide were transferred to GENOMIC SOLUTIONS scan system in order to 
get the array image. The scanned array was showed in the figure 3. 
                                             
Figure 3. Images of array after hybridizing with Cy3/5 labeled cDNAs 
The images displayed that labeled cDNA samples were hybridized well with the probes on 
the array. The color of the gene spots were totally clear. The image was also very sharp showing 
the success of the hybridization. There was big different in colors of probes. The red color 
showed that genes were up-regulated under 2B2D treatment while the green color implied down-
regulated genes. The most popular color was yellow proved that most of genes were not clearly 
effected by 2B2D exposure. However, the image and the scanning software of GeneTAC4 only 
provided several basic information. To achieve the up or down-regulated gene list, we needed to 
analyze the data with GeneSpring software from Agilent.  
3.3. Data analyzing results 
After sending the raw data to Phanlanx Biotech. Group for analysis, we achieved the whole 
list of up and down-regulated genes of LU-1 cells under 2B2D treatment.  
       
Figure 4. Data analysis with GENESPRING GX*7.3 software (Agilent Biotechnology) 
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By using GENESPRING GX*7.3 software (Agilent Biotechnology) to analysis the data, we 
found out 742 genes that got equal or over two fold changes. Among of those, there were 386 
genes up-regulated while the other 356 genes down-regulated. The Table 1 showed all details of 
the 5 genes that were the strongest effect by the drug treatment either up or down-regulation. 
Table 1. The list of the 10 genes with highest fold changes 
Up-regulated fold change Genbank Gene Symbol Description 
209930_s_at 5.985 L13974 NFE2 nuclear factor (erythroid-derived 2), 45kDa 
237086_at 5.983 AI693336     
1552673_at 5.159 NM_173560 RFXDC1 regulatory factor X domain 
containing 1 
204380_s_at 3.978 M58051 FGFR3 
fibroblast growth factor receptor 3 
(achondroplasia, thanatophoric 
dwarfism) 
219990_at 3.743 NM_024680 E2F8 E2F transcription factor 8 
Down-regulated fold change Genbank Gene Symbol Description 
207528_s_at 7.316 NM_014331 SLC7A11 
solute carrier family 7, (cationic 
amino acid transporter, y+ system) 
member 11 
209921_at 7.405 AB040875 SLC7A11 
solute carrier family 7, (cationic 
amino acid transporter, y+ system) 
member 11 
226158_at 7.583 AL120021 KLHL24 kelch-like 24 (Drosophila) 
241418_at 7.725 AI819386   Hypothetical LOC344887 
217678_at 7.728 AA488687 SLC7A11 
solute carrier family 7, (cationic 
amino acid transporter, y+ system) 
member 11 
From the list above we can see the nuclear factor (erythroid-derived 2, regulatory factor X 
domain containing 1, fibroblast growth factor receptor 3 (achondroplasia, thanatophoric 
dwarfism) and E2F transcription factor 8 were up-regulated. Those genes were stimulated by our 
compound 2B2D. The other genes that encoded for solute carrier family 7 (cationic amino acid 
transporter, y+ system) member 11, kelch-like 24 and Hypothetical LOC344887 were strongly 
inhibited lead to down in action. 
4. CONCLUSION 
By using the advantages of microarray technique, we investigated the acting mechanism of 
the potential anticancer compound 2B2D at the molecular level on LU-1 cells. There were 386 
genes up-regulated while the other 356 genes down-regulated. The nuclear factor (erythroid-
derived 2, regulatory factor X domain containing 1, fibroblast growth factor receptor 3 
(achondroplasia, thanatophoric dwarfism) and E2F transcription factor 8 were the most 
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stimulated by our compound. The genes that named as solute carrier family 7 (cationic amino 
acid transporter, y+ system) member 11, kelch-like 24 and Hypothetical LOC344887 were the 
most down in action. 
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NGHIÊN CỨU CƠ CHẾ KHÁNG UNG THƯ CỦA HỢP CHẤT TIỀM NĂNG 2B2D BẰNG 
KĨ THUẬT MICROARRAY 
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Là một kĩ thuật mới với khả năng nghiên cứu, phát hiện, giám sát và phân tích sự biểu hiện 
của hàng ngàn, thậm chí là cả hệ genome trong cùng một thí nghiệm duy nhất, microarray tỏ ra 
là một công cụ hữu hiệu giúp ích cho các nghiên cứu về ung thư học, đặc biệt là về mặt cơ chế 
phân tử. Với việc sử dụng hoạt chất tiềm năng chống ung thư 1-(5,7-dimetoxy-2,2-dimetyl-2H-
cromen-8-yl)-but-2-en-1-on (gọi tắt là 2B2D) và dòng tế bào ung thư phổi người LU-1 làm đối 
tượng nghiên cứu, chúng tôi đã lai thành công các mẫu cDNA có gắn chất nhuộm màu huỳnh 
quang cyanine 3/5 với chip Phalanx HOV5 microarray. Kết quả cho thấy 742 gen có mức độ 
biểu hiện bị thay đổi lớn hơn hoặc bằng hai lần khi chịu tác động của hoạt chất 2B2D. Trong số 
này, 386 gen tăng cường hoạt động và ngược lại, có 356 gen bị giảm mức độ biểu hiện. Các gen 
qui định cho Nuclear factor (erythroid-derived 2, regulatory factor X domain containing 1, 
fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) và E2F 
transcription factor 8 bị kích thích và có mức độ biểu hiện tăng cường mạnh nhất dưới tác động 
của hoạt chất. Các gen có tên như Carrier family 7 (cationic amino acid transporter, y+ system) 
member 11, kelch-like 24 và Hypothetical LOC344887 bị ức chế biểu hiện mạnh nhất. 
Từ khoá: cDNA, cyanine, LU-1, Mallotus apelta, microarray, spectrophotometer 
 
